These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20844588)

  • 1. Nucleo-cytoplasmic localization domains regulate Krüppel-like factor 6 (KLF6) protein stability and tumor suppressor function.
    Rodríguez E; Aburjania N; Priedigkeit NM; DiFeo A; Martignetti JA
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
    Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
    Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of KLF6 and its splice variants in cancer therapy.
    DiFeo A; Martignetti JA; Narla G
    Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.
    Liang WC; Wang Y; Xiao LJ; Wang YB; Fu WM; Wang WM; Jiang HQ; Qi W; Wan DC; Zhang JF; Waye MM
    RNA Biol; 2014; 11(7):845-54. PubMed ID: 24921656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
    Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
    Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of ESE-1 subdomains required to initiate mammary epithelial cell transformation via a cytoplasmic mechanism.
    Prescott JD; Poczobutt JM; Tentler JJ; Walker DM; Gutierrez-Hartmann A
    Mol Cancer; 2011 Aug; 10():103. PubMed ID: 21871131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.
    Narla G; DiFeo A; Fernandez Y; Dhanasekaran S; Huang F; Sangodkar J; Hod E; Leake D; Friedman SL; Hall SJ; Chinnaiyan AM; Gerald WL; Rubin MA; Martignetti JA
    J Clin Invest; 2008 Aug; 118(8):2711-21. PubMed ID: 18596922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted reduction of KLF6-SV1 restores chemotherapy sensitivity in resistant lung adenocarcinoma.
    Sangodkar J; DiFeo A; Feld L; Bromberg R; Schwartz R; Huang F; Terzo EA; Choudhri A; Narla G
    Lung Cancer; 2009 Dec; 66(3):292-7. PubMed ID: 19328586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer.
    Chen H; Chen L; Sun L; Zhen H; Li X; Zhang Q
    Gastric Cancer; 2011 Oct; 14(4):339-52. PubMed ID: 21538018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21.
    Lang UE; Kocabayoglu P; Cheng GZ; Ghiassi-Nejad Z; Muñoz U; Vetter D; Eckstein DA; Hannivoort RA; Walsh MJ; Friedman SL
    Oncogene; 2013 Sep; 32(38):4557-64. PubMed ID: 23085750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear expression of KLF6 tumor suppressor factor is highly associated with overexpression of ERBB2 oncoprotein in ductal breast carcinomas.
    Gehrau RC; D'Astolfo DS; Dumur CI; Bocco JL; Koritschoner NP
    PLoS One; 2010 Jan; 5(1):e8929. PubMed ID: 20126619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic residues within the Kruppel zinc finger DNA binding domains are the critical nuclear localization determinants of EKLF/KLF-1.
    Pandya K; Townes TM
    J Biol Chem; 2002 May; 277(18):16304-12. PubMed ID: 11844803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of the KLF6 tumour suppressor gene in gastric cancer.
    Sangodkar J; Shi J; DiFeo A; Schwartz R; Bromberg R; Choudhri A; McClinch K; Hatami R; Scheer E; Kremer-Tal S; Martignetti JA; Hui A; Leung WK; Friedman SL; Narla G
    Eur J Cancer; 2009 Mar; 45(4):666-76. PubMed ID: 19101139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-dependent corepressor (LCoR) recruitment by Kruppel-like factor 6 (KLF6) regulates expression of the cyclin-dependent kinase inhibitor CDKN1A gene.
    Calderon MR; Verway M; An BS; DiFeo A; Bismar TA; Ann DK; Martignetti JA; Shalom-Barak T; White JH
    J Biol Chem; 2012 Mar; 287(12):8662-74. PubMed ID: 22277651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor.
    DiFeo A; Narla G; Camacho-Vanegas O; Nishio H; Rose SL; Buller RE; Friedman SL; Walsh MJ; Martignetti JA
    Oncogene; 2006 Sep; 25(44):6026-31. PubMed ID: 16702959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.
    Andreoli V; Gehrau RC; Bocco JL
    IUBMB Life; 2010 Dec; 62(12):896-905. PubMed ID: 21154818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Krüppel-like factor 6 expression changes during trophoblast syncytialization and transactivates ßhCG and PSG placental genes.
    Racca AC; Camolotto SA; Ridano ME; Bocco JL; Genti-Raimondi S; Panzetta-Dutari GM
    PLoS One; 2011; 6(7):e22438. PubMed ID: 21799854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A masked PY-NLS in Drosophila TIS11 and its mammalian homolog tristetraprolin.
    Twyffels L; Wauquier C; Soin R; Decaestecker C; Gueydan C; Kruys V
    PLoS One; 2013; 8(8):e71686. PubMed ID: 23951221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing.
    Vetter D; Cohen-Naftaly M; Villanueva A; Lee YA; Kocabayoglu P; Hannivoort R; Narla G; M Llovet J; Thung SN; Friedman SL
    Hepatology; 2012 Oct; 56(4):1361-70. PubMed ID: 22535637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF6-SV1 drives breast cancer metastasis and is associated with poor survival.
    Hatami R; Sieuwerts AM; Izadmehr S; Yao Z; Qiao RF; Papa L; Look MP; Smid M; Ohlssen J; Levine AC; Germain D; Burstein D; Kirschenbaum A; DiFeo A; Foekens JA; Narla G
    Sci Transl Med; 2013 Jan; 5(169):169ra12. PubMed ID: 23345610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.